Selected research
Industry Research
Oxycodone Hydrochloride Drugs Industry Research Report 2026
Market perspective
The global Oxycodone Hydrochloride Drugs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Oxycodone Hydrochloride Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Oxycodone Hydrochloride Drugs is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Oxycodone Hydrochloride Drugs is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Oxycodone Hydrochloride Drugs include Mallinckrodt, Napp Pharmaceuticals, NEPHARM, Purdue Pharma and Wellso Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Oxycodone Hydrochloride Drugs market in terms of revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Oxycodone Hydrochloride Drugs Market by Company
Mallinckrodt
Napp Pharmaceuticals
NEPHARM
Purdue Pharma
Wellso Pharmaceutical
Oxycodone Hydrochloride Drugs Segment by Type
Oral Capsule
Intravenous Fluid
Oral Solution
Tablet
Oxycodone Hydrochloride Drugs Segment by Application
Hospitals
Clinics
Others
Oxycodone Hydrochloride Drugs Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oxycodone Hydrochloride Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oxycodone Hydrochloride Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oxycodone Hydrochloride Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Oxycodone Hydrochloride Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Oxycodone Hydrochloride Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Oxycodone Hydrochloride Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Oral Capsule
- Intravenous Fluid
- Oral Solution
- Tablet
Applications
- Hospitals
- Clinics
- Others
Companies covered
- Mallinckrodt
- Napp Pharmaceuticals
- NEPHARM
- Purdue Pharma
- Wellso Pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Oxycodone Hydrochloride Drugs Market Size (2021-2032)
- 2.2.2 Global Oxycodone Hydrochloride Drugs Sales (2021-2032)
- 2.2.3 Global Oxycodone Hydrochloride Drugs Market Average Price (2021-2032)
- 2.3 Oxycodone Hydrochloride Drugs by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Oral Capsule
- 2.3.3 Intravenous Fluid
- 2.3.4 Oral Solution
- 2.3.5 Tablet
- 2.4 Oxycodone Hydrochloride Drugs by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospitals
- 2.4.3 Clinics
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Oxycodone Hydrochloride Drugs Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Oxycodone Hydrochloride Drugs Sales (Tons) of Manufacturers (2021-2026)
- 3.3 Global Oxycodone Hydrochloride Drugs Revenue of Manufacturers (2021-2026)
- 3.4 Global Oxycodone Hydrochloride Drugs Average Price by Manufacturers (2021-2026)
- 3.5 Global Oxycodone Hydrochloride Drugs Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Oxycodone Hydrochloride Drugs, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Oxycodone Hydrochloride Drugs, Product Type & Application
- 3.8 Global Manufacturers of Oxycodone Hydrochloride Drugs, Established Date
- 3.9 Global Oxycodone Hydrochloride Drugs Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Mallinckrodt
- 4.1.1 Mallinckrodt Company Information
- 4.1.2 Mallinckrodt Business Overview
- 4.1.3 Mallinckrodt Oxycodone Hydrochloride Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Mallinckrodt Oxycodone Hydrochloride Drugs Product Portfolio
- 4.1.5 Mallinckrodt Recent Developments
- 4.2 Napp Pharmaceuticals
- 4.2.1 Napp Pharmaceuticals Company Information
- 4.2.2 Napp Pharmaceuticals Business Overview
- 4.2.3 Napp Pharmaceuticals Oxycodone Hydrochloride Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Napp Pharmaceuticals Oxycodone Hydrochloride Drugs Product Portfolio
- 4.2.5 Napp Pharmaceuticals Recent Developments
- 4.3 NEPHARM
- 4.3.1 NEPHARM Company Information
- 4.3.2 NEPHARM Business Overview
- 4.3.3 NEPHARM Oxycodone Hydrochloride Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 NEPHARM Oxycodone Hydrochloride Drugs Product Portfolio
- 4.3.5 NEPHARM Recent Developments
- 4.4 Purdue Pharma
- 4.4.1 Purdue Pharma Company Information
- 4.4.2 Purdue Pharma Business Overview
- 4.4.3 Purdue Pharma Oxycodone Hydrochloride Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Purdue Pharma Oxycodone Hydrochloride Drugs Product Portfolio
- 4.4.5 Purdue Pharma Recent Developments
- 4.5 Wellso Pharmaceutical
- 4.5.1 Wellso Pharmaceutical Company Information
- 4.5.2 Wellso Pharmaceutical Business Overview
- 4.5.3 Wellso Pharmaceutical Oxycodone Hydrochloride Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Wellso Pharmaceutical Oxycodone Hydrochloride Drugs Product Portfolio
- 4.5.5 Wellso Pharmaceutical Recent Developments
5 Global Oxycodone Hydrochloride Drugs Market Scenario by Region
- 5.1 Global Oxycodone Hydrochloride Drugs Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Oxycodone Hydrochloride Drugs Sales by Region: 2021-2032
- 5.2.1 Global Oxycodone Hydrochloride Drugs Sales by Region: 2021-2026
- 5.2.2 Global Oxycodone Hydrochloride Drugs Sales by Region: 2027-2032
- 5.3 Global Oxycodone Hydrochloride Drugs Revenue by Region: 2021-2032
- 5.3.1 Global Oxycodone Hydrochloride Drugs Revenue by Region: 2021-2026
- 5.3.2 Global Oxycodone Hydrochloride Drugs Revenue by Region: 2027-2032
- 5.4 North America Oxycodone Hydrochloride Drugs Market Facts & Figures by Country
- 5.4.1 North America Oxycodone Hydrochloride Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Oxycodone Hydrochloride Drugs Sales by Country (2021-2032)
- 5.4.3 North America Oxycodone Hydrochloride Drugs Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Oxycodone Hydrochloride Drugs Market Facts & Figures by Country
- 5.5.1 Europe Oxycodone Hydrochloride Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Oxycodone Hydrochloride Drugs Sales by Country (2021-2032)
- 5.5.3 Europe Oxycodone Hydrochloride Drugs Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Oxycodone Hydrochloride Drugs Market Facts & Figures by Country
- 5.6.1 Asia Pacific Oxycodone Hydrochloride Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Oxycodone Hydrochloride Drugs Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Oxycodone Hydrochloride Drugs Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Oxycodone Hydrochloride Drugs Market Facts & Figures by Country
- 5.7.1 South America Oxycodone Hydrochloride Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Oxycodone Hydrochloride Drugs Sales by Country (2021-2032)
- 5.7.3 South America Oxycodone Hydrochloride Drugs Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Oxycodone Hydrochloride Drugs Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Oxycodone Hydrochloride Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Oxycodone Hydrochloride Drugs Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Oxycodone Hydrochloride Drugs Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Oxycodone Hydrochloride Drugs Sales by Type (2021-2032)
- 6.1.1 Global Oxycodone Hydrochloride Drugs Sales by Type (2021-2032) & (Tons)
- 6.1.2 Global Oxycodone Hydrochloride Drugs Sales Market Share by Type (2021-2032)
- 6.2 Global Oxycodone Hydrochloride Drugs Revenue by Type (2021-2032)
- 6.2.1 Global Oxycodone Hydrochloride Drugs Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Oxycodone Hydrochloride Drugs Revenue Market Share by Type (2021-2032)
- 6.3 Global Oxycodone Hydrochloride Drugs Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Oxycodone Hydrochloride Drugs Sales by Application (2021-2032)
- 7.1.1 Global Oxycodone Hydrochloride Drugs Sales by Application (2021-2032) & (Tons)
- 7.1.2 Global Oxycodone Hydrochloride Drugs Sales Market Share by Application (2021-2032)
- 7.2 Global Oxycodone Hydrochloride Drugs Revenue by Application (2021-2032)
- 7.2.1 Global Oxycodone Hydrochloride Drugs Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Oxycodone Hydrochloride Drugs Revenue Market Share by Application (2021-2032)
- 7.3 Global Oxycodone Hydrochloride Drugs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Oxycodone Hydrochloride Drugs Value Chain Analysis
- 8.1.1 Oxycodone Hydrochloride Drugs Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Oxycodone Hydrochloride Drugs Production Mode & Process
- 8.2 Oxycodone Hydrochloride Drugs Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Oxycodone Hydrochloride Drugs Distributors
- 8.2.3 Oxycodone Hydrochloride Drugs Customers
9 Global Oxycodone Hydrochloride Drugs Analyzing Market Dynamics
- 9.1 Oxycodone Hydrochloride Drugs Industry Trends
- 9.2 Oxycodone Hydrochloride Drugs Industry Drivers
- 9.3 Oxycodone Hydrochloride Drugs Industry Opportunities and Challenges
- 9.4 Oxycodone Hydrochloride Drugs Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst